Literature DB >> 2451487

Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain).

M A Gertz1, C Y Li, T Shirahama, R A Kyle.   

Abstract

To our knowledge, this is the first blind and controlled analysis of subcutaneous fat aspiration for the diagnosis of primary systemic amyloidosis. The procedure was performed on 82 patients with biopsy-proved systemic amyloidosis and 72 normal adult volunteers. Slides from 71 of the 72 controls were read as negative. Slides from 59 (72%) of the 82 patients with amyloidosis were read as positive or weakly positive after staining with alkaline Congo red. Subcutaneous fat aspiration was as sensitive as rectal biopsy and substantially more sensitive than bone marrow biopsy in diagnosing amyloidosis. In six instances fat aspiration would have obviated the need for a more invasive diagnostic biopsy. Subcutaneous fat aspiration is sensitive (72%) and specific (99%) for amyloidosis. It is technically simpler and less expensive than rectal biopsy and permits immediate assessment of specimen adequacy. The concordance rate for two independent pathologists was 95%. Equivocally positive stains should be interpreted with caution because weak nonspecific staining may be seen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451487

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

Review 1.  Advances in Treatment of Cardiac Amyloid.

Authors:  Cherie N Dahm; R Frank Cornell; Daniel J Lenihan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-07

2.  Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.

Authors:  Brendan M Weiss; Joseph Hebreo; Daniel V Cordaro; Mark J Roschewski; Thomas P Baker; Kevin C Abbott; Stephen W Olson
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

Review 3.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

Review 4.  Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.

Authors:  Ilia G Halatchev; Jingsheng Zheng; Jiafu Ou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Diagnosis and typing of systemic amyloidosis: The role of abdominal fat pad fine needle aspiration biopsy.

Authors:  Ruba A Halloush; Elena Lavrovskaya; Dina R Mody; Donna Lager; Luan Truong
Journal:  Cytojournal       Date:  2010-01-15       Impact factor: 2.091

6.  Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.

Authors:  Julie A Vrana; Jason D Theis; Surendra Dasari; Oana M Mereuta; Angela Dispenzieri; Steven R Zeldenrust; Morie A Gertz; Paul J Kurtin; Karen L Grogg; Ahmet Dogan
Journal:  Haematologica       Date:  2014-04-18       Impact factor: 9.941

Review 7.  Primary amyloidosis and severe intrahepatic cholestatic jaundice.

Authors:  R A Peters; G Koukoulis; A Gimson; B Portmann; D Westaby; R Williams
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

8.  Biopsy of subcutaneus fatty tissue for diagnosis of systemic amyloidosis.

Authors:  B Bogov; M Lubomirova; B Kiperova
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

Review 9.  Amyloid in surgical pathology.

Authors:  Christoph Röcken; Knut Sletten
Journal:  Virchows Arch       Date:  2003-06-11       Impact factor: 4.064

10.  Autopsy findings in a patient with primary systemic AL (kappa light chain) amyloidosis.

Authors:  Felipe Lourenço Ledesma; Jussara Bianchi Castelli
Journal:  Autops Case Rep       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.